2-tert-butylhydroquinone has been researched along with Encephalopathy, Traumatic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Chen, F; Li, XH; Liang, J; Sun, HT; Tu, Y; Wang, JJ; Yan, JX; Ye, YC; Zhang, ZW | 1 |
| Chandran, R; Mehta, SL; Vemuganti, R | 1 |
| Cengiz, P; Chanana, V; Chandran, R; Kim, C; Kim, H; Kim, T; Mehta, SL; Udho, E; Vemuganti, R | 1 |
3 other study(ies) available for 2-tert-butylhydroquinone and Encephalopathy, Traumatic
| Article | Year |
|---|---|
TBHQ improved neurological recovery after traumatic brain injury by inhibiting the overactivation of astrocytes.
Topics: Animals; Antioxidants; Apoptosis; Astrocytes; Brain Injuries, Traumatic; Disease Models, Animal; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Hydroquinones; Male; Microglia; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Tumor Necrosis Factor-alpha | 2020 |
Antioxidant Combo Therapy Protects White Matter After Traumatic Brain Injury.
Topics: Acetophenones; Animals; Antioxidants; Brain Injuries, Traumatic; Drug Administration Schedule; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Gray Matter; Hydroquinones; Male; Mice; Mice, Inbred C57BL; NADPH Oxidase 2; NF-E2-Related Factor 2; Oxidative Stress; Random Allocation; White Matter | 2021 |
A combination antioxidant therapy to inhibit NOX2 and activate Nrf2 decreases secondary brain damage and improves functional recovery after traumatic brain injury.
Topics: Acetophenones; Animals; Antioxidants; Brain; Brain Injuries, Traumatic; Hydroquinones; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NADPH Oxidase 2; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidative Stress; Recovery of Function | 2018 |